Mass Spectrometry as a First-Line Diagnostic Aid for Congenital Disorders of Glycosylation

There was an error in Mass Spectrometry 14: A0169 (2025).

Figure 2, shown below, was not correct:

The correct figure is as follows:

Fig. 2 Biosynthetic pathway of N-glycans in the ER and Golgi apparatus. The CDG in which patients have been identified to date is listed in the box. This figure is a modified version of Fig. 2 from Chapter 45 of Essentials of Glycobiology, 4th Edition (https://www.ncbi.nlm.nih.gov/books/NBK579928/). CDG, congenital disorders of glycosylation; ER, endoplasmic reticulum.

Related Articles

• https://doi.org/10.5702/massspectrometry.A0169